Citius Pharmaceuticals
CTXR
CTXR
74 hedge funds and large institutions have $17.1M invested in Citius Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
6% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 18
44% less capital invested
Capital invested by funds: $30.4M → $17.1M (-$13.3M)
Holders
74
Holding in Top 10
–
Calls
$281K
Puts
$40K
Top Buyers
| 1 | +$105K | |
| 2 | +$100K | |
| 3 | +$76.3K | |
| 4 |
AWA
Arkadios Wealth Advisors
Atlanta,
Georgia
|
+$68.4K |
| 5 |
State Street
Boston,
Massachusetts
|
+$65.4K |
Top Sellers
| 1 | -$201K | |
| 2 | -$162K | |
| 3 | -$120K | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$101K |
| 5 |
Jane Street
New York
|
-$86.1K |